X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 16/Dec 12:35

ZBH Stock Might Rise Following FDA Nod for OsseoFit

Zimmer Biomet's OsseoFit Stemless Shoulder System gets FDA 510(k) approval. The company expects to launch the system in the first quarter of 2025.

Articles similaires

Sorry! Image not available at this time

Ionis Gets FDA Approval for Rare Disease Drug Tryngolza

zacks.com - 20/Dec 13:03

The FDA's nod to IONS' Tryngolza makes it the first approved treatment for FCS. It is also the company's first wholly-owned drug to receive marketing...

Sorry! Image not available at this time

MBOT Stock Gains Following FDA Submission of the LIBERTY System

zacks.com - 12/Dec 16:51

Microbot Medical announces the submission of its LIBERTY System for FDA marketing clearance.

Sorry! Image not available at this time

ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife

zacks.com - 10/Dec 16:14

AngioDynamics' latest regulatory approval is likely to pave the way for an alternative to conventional radical surgery and improve patient outcomes.

First Aussie-made and launched rocket gets approval

thewest.com.au - 16/Dec 02:51

An Australian company has been given first-of-its-kind approval to launch a rocket out of a small Queensland town.

First Aussie-made and launched rocket gets approval

thewest.com.au - 16/Dec 02:51

An Australian company has been given first-of-its-kind approval to launch a rocket out of a small Queensland town.

FDA pre-approval inspection of EBR’s WiSE CRT system set for early January

stockhead.com.au - 19/Dec 22:55

The US FDA has scheduled a pre-approval inspection of EBR System’s WiSE CRT System for the week of January 6, ...

Sorry! Image not available at this time

QURE Soars on FDA Alignment for Speedy Approval of Huntington's Drug

zacks.com - 11/Dec 15:02

uniQure stock rallies 110% on reaching alignment with the FDA on key elements of an accelerated approval pathway for AMT-130 to treat Huntington's...

Sorry! Image not available at this time

GSK Gets CHMP Nod for Expanded Use of HIV Combo & Jemperli

zacks.com - 17/Dec 15:43

The CHMP recommends marketing approval to GSK's Vocabria plus JNJ's Rekambys for treating HIV-1 infection in adolescents aged 12 years and older.

Sorry! Image not available at this time

MESO Stock Up as FDA Approves Ryoncil for Graft Versus Host Disease

zacks.com - 19/Dec 18:16

The FDA approves Mesoblast's Ryoncil (remestemcel-L) for treating pediatric patients with steroid-refractory acute graft versus host disease. Shares...

Sorry! Image not available at this time

MESO Stock Up as FDA Approves Ryoncil for Graft Versus Host Disease

zacks.com - 19/Dec 18:16

The FDA approves Mesoblast's Ryoncil (remestemcel-L) for treating pediatric patients with steroid-refractory acute graft versus host disease. Shares...